Event Details
Circa 2015
Description
The ODYSSEY clinical trial program was conducted for the drug Praluent.
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| patients | person | 2 | View Entity |
| Investigators | person | 26 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_026364.jpg
This article discusses the new cholesterol drug, Praluent, from Regeneron and Sanofi, focusing on its high price, which is 46% higher than analyst forecasts. It details the FDA's approval for a broader patient group than expected, the potential for wide prescription by doctors despite the label, and the expected resistance from insurance companies who will likely restrict its use. The article also includes commentary from executives at Regeneron and Sanofi, as well as analysts and cardiologists, on the drug's market potential and place alongside existing treatments like statins.
Related Events
Events with shared participants
ODYSSEY Phase 3 program: A comprehensive clinical trial program for an investigational LDL cholesterol lowering therapy (Praluent), involving 14 global trials and over 23,500 patients.
Date unknown • Global
ODYSSEY Phase 3 program: A comprehensive clinical trial program for PRALUENT, including 14 global trials with over 23,500 patients.
Date unknown • Global
ODYSSEY Phase 3 program: A large-scale clinical trial program for the investigational LDL cholesterol-lowering therapy, Praluent (alirocumab), involving over 23,500 patients in 14 global trials.
Date unknown • Global
Cohen is under investigation for bank fraud and violating campaign-finance law.
Date unknown • U.S.
Discovery of hidden cameras
Date unknown • Epstein's New York Residence
Defense team investigators compiled dossiers on victims.
Date unknown • Not specified
SEC Deposition of Jeffrey Epstein regarding his departure from Bear Stearns.
1989-01-01 • Unknown
NSA investigators made initial assessment of the theft.
2025-07-01 • NSA
An attempted interview of a female subject by Alan Dershowitz's investigators.
Date unknown
According to Villafaña, in 2007 investigators did not have specific evidence against Epstein's close female friend.
2007-01-01
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event